Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.39 USD 6.5% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Wall Street
Price Targets

NEO Price Targets Summary
Neogenomics Inc

Wall Street analysts forecast NEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEO is 20.91 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

Lowest
Price Target
16.16 USD
1% Downside
Average
Price Target
20.91 USD
28% Upside
Highest
Price Target
31.5 USD
92% Upside

NEO Last Price Targets
Neogenomics Inc

The latest public price target was made on Jul 30, 2024 by Mike Matson from Needham , who expects NEO stock to rise by 16% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Mike Matson
Needham
19 USD
Upside 16%
3 months ago
Jul 30, 2024
Needham Reiterates Buy Rating on Neogenomics (NEO)
StreetInsider
Mark Massaro
BTIG
21 USD
Upside 28%
6 months ago
May 2, 2024
Neogenomics (NEO) PT Lowered to $21 at BTIG
StreetInsider
Mason Carrico
Stephens
18 USD
Upside 10%
1 year ago
Aug 21, 2023
Stephens Upgrades Neogenomics (NEO) to Overweight
StreetInsider
Mike Matson
Needham
Price Target 19 USD
Upside/Downside 16%
View Source
Mark Massaro
BTIG
Price Target 21 USD
Upside/Downside 28%
View Source
Mason Carrico
Stephens
Price Target 18 USD
Upside/Downside 10%
View Source
Neogenomics Inc Competitors:
Price Targets
QTRX
Quanterix Corp
76% Upside
CDXS
Codexis Inc
52% Upside
ADPT
Adaptive Biotechnologies Corp
61% Upside
SEER
Seer Inc
26% Upside
A
Agilent Technologies Inc
13% Upside
MRVI
Maravai LifeSciences Holdings Inc
90% Upside
300404
Boji Medical Technology Co Ltd
38% Upside
QSI
Quantum-Si Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Neogenomics Inc

For the last 8 years the compound annual growth rate for Neogenomics Inc's revenue is 25%. The projected CAGR for the next 3 years is 11%.

25%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Neogenomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Net Income
Forecast

Net Income Estimate
Neogenomics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NEO's stock price target?
Price Target
20.91 USD

According to Wall Street analysts, the average 1-year price target for NEO is 20.91 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

What is Neogenomics Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Neogenomics Inc's revenue is 25%. The projected CAGR for the next 3 years is 11%.

Back to Top